Scientific Advisory Board Member
Donald L. Trump, MD, FACP is President and CEO of the Roswell Park Cancer Institute. Dr. Trump is a nationally recognized medical oncologist whose clinical and research program has focused on the development of new approaches in the treatment of genitourinary cancer, especially prostate cancer. For the past 15 years Dr. Trump and his colleague, Dr. Candace Johnson, Deputy Director of the Roswell Park Cancer Institute have focused their research efforts on the evaluation of the biologic and clinical role of vitamin D and vitamin D analogues in cancer etiology and therapeutics.
Dr. Trump received his Bachelor of Science and Doctor of Medicine degrees from The Johns Hopkins University. He served his medical residency and was chief resident in medicine on the Osler Medical Service at The Johns Hopkins Hospital and was an oncology fellow at the Johns Hopkins Oncology Center. Dr. Trump has held leadership positions in the Wisconsin Clinical Cancer Center, the Duke University Comprehensive Cancer Center and the University of Pittsburgh Cancer Institute prior to his position at Roswell Park. Dr. Trump has held NCI peer reviewed funding continuously since 1986 and has also been funded by the ACS and DOD. He has held national leadership positions in ECOG, CALGB and ASCO and ACoS-CoC and has served NIH study sections both as an ad hoc and permanent member (ET2, CONC, subcommittee H and CCSG review committees).